Although exhausted PD-1+ effector T cells are less proficient at ImmTAC®-mediated killing of PD-L1+ tumor cells in vitro, cytotoxic activity can be rescued with an anti-PD-1 blocking antibody. The gene discussed is PDCD1; the disease is neoplasm.